Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.
作者信息
Bahat G
机构信息
Gülistan Bahat, Istanbul University, Istanbul Medical School, Department of Internal Medicine, Division of Geriatrics, Fatih 34093, Istanbul, Turkey, Telephone: +90 212 414 20 00, Fax: + 90 212 414 22 48, + 90 212 532 42 08, E-Mail Address:
出版信息
J Nutr Health Aging. 2020;24(7):699-704. doi: 10.1007/s12603-020-1403-7.
Abstract
摘要
相似文献
1
Covid-19 and the Renin Angiotensin System: Implications for the Older Adults.新冠病毒与肾素-血管紧张素系统：对老年人的影响
J Nutr Health Aging. 2020;24(7):699-704. doi: 10.1007/s12603-020-1403-7.
2
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.严重急性呼吸综合征冠状病毒2型发病机制：肾素-血管紧张素系统失衡促进肺纤维化。
Front Cell Infect Microbiol. 2020 Jun 12;10:340. doi: 10.3389/fcimb.2020.00340. eCollection 2020.
3
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.心力衰竭背景下COVID-19对肾素-血管紧张素系统的干扰
mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20.
4
Coronavirus disease 2019 infection and the cardiovascular system.2019冠状病毒病感染与心血管系统
J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):403-405. doi: 10.2459/JCM.0000000000000980.
5
Sarcopenia and COVID-19: A Manifold Insight on Hypertension and the Renin Angiotensin System.肌肉减少症与2019冠状病毒病：对高血压和肾素血管紧张素系统的多方面洞察
Am J Phys Med Rehabil. 2020 Oct;99(10):880-882. doi: 10.1097/PHM.0000000000001528.
6
Can beta-adrenergic blockers be used in the treatment of COVID-19?β-肾上腺素能阻滞剂可用于治疗新型冠状病毒肺炎吗？
Med Hypotheses. 2020 Sep;142:109809. doi: 10.1016/j.mehy.2020.109809. Epub 2020 May 5.
7
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题？]
Lakartidningen. 2020 Apr 17;117:F3S3.
8
[Not Available].[无可用内容]。
Rev Med Suisse. 2020 May 6;16(692):947-949.
9
[Renin-Angiotensin-System (RAS) and COVID-19 - On The Prescription of RAS Blockers].[肾素-血管紧张素系统（RAS）与2019冠状病毒病——关于RAS阻滞剂的处方]
Pneumologie. 2020 Sep;74(9):611-614. doi: 10.1055/a-1165-6994. Epub 2020 Sep 11.
10
[Not Available].[无可用内容]。
Rev Med Suisse. 2020 Aug 5;16(701):1466-1467.
引用本文的文献
1
Effects of physical training on coagulation parameters, interleukin-6, and angiotensin-converting enzyme-2 in COVID-19 survivors.身体训练对 COVID-19 幸存者凝血参数、白细胞介素-6 和血管紧张素转换酶-2 的影响。
Sci Rep. 2024 Aug 16;14(1):18968. doi: 10.1038/s41598-024-67522-8.
2
Respiratory issues in patients with multiple sclerosis as a risk factor during SARS-CoV-2 infection: a potential role for exercise.多发性硬化症患者在感染 SARS-CoV-2 期间的呼吸问题：运动的潜在作用。
Mol Cell Biochem. 2023 Jul;478(7):1533-1559. doi: 10.1007/s11010-022-04610-1. Epub 2022 Nov 21.
3
Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.肾素-血管紧张素系统在新型冠状病毒肺炎相关神经表现发展中的作用。
Front Cell Neurosci. 2022 Sep 16;16:977039. doi: 10.3389/fncel.2022.977039. eCollection 2022.
4
Frequency and factors associated with sarcopenia prediction in adult and elderly patients hospitalized for COVID-19.因 COVID-19 住院的成年和老年患者中肌少症预测的频率和相关因素。
Exp Gerontol. 2022 Oct 15;168:111945. doi: 10.1016/j.exger.2022.111945. Epub 2022 Sep 5.
5
Symptomatology and imaging findings in early post-Covid period: A comparative study in older vs younger patients.新冠病毒感染后早期的症状和影像学表现：老年患者与年轻患者的对比研究。
Exp Gerontol. 2022 Oct 1;167:111907. doi: 10.1016/j.exger.2022.111907. Epub 2022 Aug 6.
6
Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients.虚弱和强健患者出院后长期新冠症状的患病率
Front Med (Lausanne). 2022 Jul 14;9:834887. doi: 10.3389/fmed.2022.834887. eCollection 2022.
7
Insight into COVID-19's epidemiology, pathology, and treatment.深入了解新型冠状病毒肺炎的流行病学、病理学及治疗方法。
Heliyon. 2022 Jan;8(1):e08799. doi: 10.1016/j.heliyon.2022.e08799. Epub 2022 Jan 19.
8
Associations between homocysteine, inflammatory cytokines and sarcopenia in Chinese older adults with type 2 diabetes.中国 2 型糖尿病老年患者同型半胱氨酸、炎性细胞因子与肌肉减少症的相关性研究。
BMC Geriatr. 2021 Dec 15;21(1):692. doi: 10.1186/s12877-021-02622-y.
9
Post-COVID-19 acute sarcopenia: physiopathology and management.新冠后急性肌肉减少症：病理生理学和管理。
Aging Clin Exp Res. 2021 Oct;33(10):2887-2898. doi: 10.1007/s40520-021-01942-8. Epub 2021 Jul 30.
10
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI).意大利内科学会（SIMI）的 SIMI-COVID-19 研究对意大利内科病房管理的 3044 例 COVID-19 患者的死亡相关临床因素进行了分析。
Intern Emerg Med. 2021 Jun;16(4):1005-1015. doi: 10.1007/s11739-021-02742-8. Epub 2021 Apr 24.
本文引用的文献
1
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
2
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.肾素-血管紧张素-醛固酮系统阻滞剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2431-2440. doi: 10.1056/NEJMoa2006923. Epub 2020 May 1.
3
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.心血管疾病、药物治疗与新冠病毒感染相关死亡率
N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621. Epub 2020 May 1.
4
Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新型冠状病毒肺炎
N Engl J Med. 2020 Jun 18;382(25):2462-2464. doi: 10.1056/NEJMe2012924. Epub 2020 May 1.
5
Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation.重症监护病房中应对新型冠状病毒肺炎：血管功能障碍、血栓形成与炎症失调
Intensive Care Med. 2020 Jun;46(6):1105-1108. doi: 10.1007/s00134-020-06059-6. Epub 2020 Apr 28.
6
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体：免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
7
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China.中国武汉因 2019 年冠状病毒病（COVID-19）感染而住院的高血压患者中，肾素-血管紧张素系统抑制剂与严重程度或死亡风险的关系。
JAMA Cardiol. 2020 Jul 1;5(7):825-830. doi: 10.1001/jamacardio.2020.1624.
8
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection.轻度症状的 SARS-CoV-2 感染门诊患者的嗅觉或味觉改变。
JAMA. 2020 May 26;323(20):2089-2090. doi: 10.1001/jama.2020.6771.
9
The impact of nutrition on COVID-19 susceptibility and long-term consequences.营养对 COVID-19 易感性和长期后果的影响。
Brain Behav Immun. 2020 Jul;87:53-54. doi: 10.1016/j.bbi.2020.04.040. Epub 2020 Apr 18.
10
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
Zotero 插件